Company · founded 2008
OpenCell Technologies (United States)
St Louis, United States · opencelltech.com
- Citations, last 5 years
- 0
- Works, last 5 years
- 0
- h-index
- 11
- Scientists listed
- 0
- Grants since 2016
- 7
Grants received
2019–2021 · research · R43
Developing a Platform for Multiplexed Large Payload Delivery
Elizabeth Schramm · OpenCell Technologies (United States) · funded by National Institutes of Health
2018–2021 · research · R01
Ph1/2 Study of FCX-007 for Treatment of RDEB IND 16582 Protocolv4.1 (11/23/2016)
John Michael Maslowski · OpenCell Technologies (United States) · funded by U.S. Food and Drug Administration
2018–2022 · research · R01
Ph1/2 Study of FCX-007 for Treatment of RDEB IND 16582 Protocolv4.1 (11/23/2016)
John Michael Maslowski · OpenCell Technologies (United States) · funded by U.S. Food and Drug Administration
2018–2024 · research · R44
Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics
Michael M Binkley · OpenCell Technologies (United States) · funded by National Institutes of Health
2018–2019 · research · R43
Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics
Elizabeth Schramm · OpenCell Technologies (United States) · funded by National Institutes of Health
2018–2023 · research · R44
Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics
Michael M Binkley · OpenCell Technologies (United States) · funded by National Institutes of Health
2018–2022 · research · R01
Ph1/2 Study of FCX-007 for Treatment of RDEB IND 16582 Protocolv4.1 (11/23/2016)
John Michael Maslowski · OpenCell Technologies (United States) · funded by U.S. Food and Drug Administration
